ONCOLOGY

Epidemiology of Ovarian Cancer: An Update

Jan 31, 2017 by in ONCOLOGY Comments Off on Epidemiology of Ovarian Cancer: An Update

Fig. 1.1 Worldwide ovarian cancer incidence and mortality rates. Rates are per 100,000 and represent age-standardized rates according to the world standard population (ASR (W)) (From the International Agency for…

read more

Strategies for the Management of Ovarian Cancer

Jan 31, 2017 by in ONCOLOGY Comments Off on Strategies for the Management of Ovarian Cancer

9. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients…

read more

Apoptosis Induction and Regulation

Jan 28, 2017 by in ONCOLOGY Comments Off on Apoptosis Induction and Regulation

(1) Institut Bergonié, Bordeaux, France   Abstract Apoptosis is one of the main modalities of cell death, so important that it has outshined all others that only begin to be…

read more

Cell Cycle Control

Jan 28, 2017 by in ONCOLOGY Comments Off on Cell Cycle Control

(1) Institut Bergonié, Bordeaux, France   Abstract Cell cycle consists of the sequential events occurring between the emergence of a new cell and that of the two daughter cells generated…

read more

Signalling by Oxygen and Nitric Oxide

Jan 28, 2017 by in ONCOLOGY Comments Off on Signalling by Oxygen and Nitric Oxide

(1) Institut Bergonié, Bordeaux, France   Abstract Oxygen is, first of all, the combustive agent required for life and the provider of energy required by all heterotrophic organisms, those which…

read more

Phosphatidylinositol 3-Kinase Pathway

Jan 28, 2017 by in ONCOLOGY Comments Off on Phosphatidylinositol 3-Kinase Pathway

(1) Institut Bergonié, Bordeaux, France   Abstract The phosphatidylinositol 3-kinase (PI3K) pathway is one of the signalling pathways activated following the interaction of a growth factor with a tyrosine kinase…

read more

Growth Factors and Tyrosine Kinase Receptors

Jan 28, 2017 by in ONCOLOGY Comments Off on Growth Factors and Tyrosine Kinase Receptors

(1) Institut Bergonié, Bordeaux, France   Abstract Signalling pathways originating from the interaction between growth factors (GF) and tyrosine kinase receptors (TKRs) are certainly the best known because of their…

read more

Toll-Like Receptors, Interleukin 1 and NFκB

Jan 28, 2017 by in ONCOLOGY Comments Off on Toll-Like Receptors, Interleukin 1 and NFκB

(1) Institut Bergonié, Bordeaux, France   Abstract Toll-like receptors (TLR) constitute a family of receptors involved in immune and inflammatory processes, which recognise molecules derived from infectious agents (bacteria, viruses)…

read more

G-Protein-Coupled Receptors

Jan 28, 2017 by in ONCOLOGY Comments Off on G-Protein-Coupled Receptors

(1) Institut Bergonié, Bordeaux, France   Abstract G-protein-coupled receptors (GPCRs) constitute a huge family of membrane receptors to numerous hormones, neurotransmitters and diverse compounds. A large part of cardiovascular and…

read more

Nuclear Receptor Pathways

Jan 28, 2017 by in ONCOLOGY Comments Off on Nuclear Receptor Pathways

(1) Institut Bergonié, Bordeaux, France   Abstract Nuclear receptors constitute a special class of transcription factors that are activated by an extracellular signal. This signal is a hydrophobic substance, such…

read more
Get Clinical Tree app for offline access